A. Gordon Robertson,Jaegil Kim,Hikmat Al-Ahmadie,Joaquim Bellmunt,Guangwu Guo,Andrew D. Cherniack,Toshinori Hinoue,Peter W. Laird,Katherine A. Hoadley,Rehan Akbani,Mauro A.A. Castro,Ewan A. Gibb,Rupa S. Kanchi,Dmitry A. Gordenin,Sachet A. Shukla,Francisco Sanchez-Vega,Donna E. Hansel,Bogdan A. Czerniak,Victor E. Reuter,Xiaoping Su,Benilton de Sa Carvalho,Vinicius S. Chagas,Karen L. Mungall,Sara Sadeghi,Chandra Sekhar Pedamallu,Yiling Lu,Leszek J. Klimczak,Jiexin Zhang,Caleb Choo,Akinyemi I. Ojesina,Susan Bullman,Kristen M. Leraas,Tara M. Lichtenberg,Catherine J. Wu,Nicholaus Schultz,Gad Getz,Matthew Meyerson,Gordon B. Mills,David J. McConkey,TCGA Research Network,Rehan Akbani,Hikmat Al-Ahmadie,Monique Albert,Iakovina Alexopoulou,Adrian Ally,Tatjana Antic,Manju Aron,Miruna Balasundaram,John Bartlett,Stephen B. Baylin,Allison Beaver,Joaquim Bellmunt,Inanc Birol,Lori Boice,Moiz S. Bootwalla,Jay Bowen,Reanne Bowlby,Denise Brooks,Bradley M. Broom,Wiam Bshara,Susan Bullman,Eric Burks,Flavio M. Cárcano,Rebecca Carlsen,Benilton S. Carvalho,Andre L. Carvalho,Eric P. Castle,Mauro A.A. Castro,Patricia Castro,James W. Catto,Vinicius S. Chagas,Andrew D. Cherniack,David W. Chesla,Caleb Choo,Eric Chuah,Sudha Chudamani,Victoria K. Cortessis,Sandra L. Cottingham,Daniel Crain,Erin Curley,Bogdan A. Czerniak,Siamak Daneshmand,John A. Demchok,Noreen Dhalla,Hooman Djaladat,John Eckman,Sophie C. Egea,Jay Engel,Ina Felau,Martin L. Ferguson,Johanna Gardner,Julie M. Gastier-Foster,Mark Gerken,Gad Getz,Ewan A. Gibb,Carmen R. Gomez-Fernandez,Dmitry A. Gordenin,Guangwu Guo,Donna E. Hansel,Jodi Harr,Arndt Hartmann,Lynn M. Herbert,Toshinori Hinoue,Thai H. Ho,Katherine A. Hoadley,Robert A. Holt,Carolyn M. Hutter,Steven J.M. Jones,Merce Jorda,Richard J. Kahnoski,Rupa S. Kanchi,Katayoon Kasaian,Jaegil Kim,Leszek J. Klimczak,David J. Kwiatkowski,Phillip H. Lai,Peter W. Laird,Brian R. Lane,Kristen M. Leraas,Seth P. Lerner,Tara M. Lichtenberg,Jia Liu,Laxmi Lolla,Yair Lotan,Yiling Lu,Fabiano R. Lucchesi,Yussanne Ma,Roberto D. Machado,Dennis T. Maglinte,David Mallery,Marco A. Marra,Sue E. Martin,Michael Mayo,David J. McConkey,Anoop Meraney,Matthew Meyerson,Gordon B. Mills,Alireza Moinzadeh,Richard A. Moore,Edna M. Mora Pinero,Scott Morris,Carl Morrison,Karen L. Mungall,Andrew J. Mungall,Jerome B. Myers,Rashi Naresh,Peter H. O'Donnell,Akinyemi I. Ojesina,Dipen J. Parekh,Jeremy Parfitt,Joseph D. Paulauskis,Chandra Sekhar Pedamallu,Robert J. Penny,Todd Pihl,Sima Porten,Mario E. Quintero-Aguilo,Nilsa C. Ramirez,W. Kimryn Rathmell,Victor E. Reuter,Kimberly Rieger-Christ,A. Gordon Robertson,Sara Sadeghi,Charles Saller,Andrew Salner,Francisco Sanchez-Vega,George Sandusky,Cristovam Scapulatempo-Neto,Jacqueline E. Schein,Anne K. Schuckman,Nikolaus Schultz,Candace Shelton,Troy Shelton,Sachet A. Shukla,Jeff Simko,Parminder Singh,Payal Sipahimalani,Norm D. Smith,Heidi J. Sofia,Andrea Sorcini,Melissa L. Stanton,Gary D. Steinberg,Robert Stoehr,Xiaoping Su,Travis Sullivan,Qiang Sun,Angela Tam,Roy Tarnuzzer,Katherine Tarvin,Helge Taubert,Nina Thiessen,Leigh Thorne,Kane Tse,Kelinda Tucker,David J. Van Den Berg,Kim E. van Kessel,Sven Wach,Yunhu Wan,Zhining Wang,John N. Weinstein,Daniel J. Weisenberger,Lisa Wise,Tina Wong,Ye Wu,Catherine J. Wu,Liming Yang,Leigh Anne Zach,Jean C. Zenklusen,Jiashan Zhang,Jiexin Zhang,Erik Zmuda,Ellen C. Zwarthoff,John N. Weinstein,David J. Kwiatkowski,Seth P. Lerner,Jiashan (Julia) Zhang

Abstract:We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized by multiple TCGA analytical platforms. Fifty-eight genes were significantly mutated, and the overall mutational load was associated with APOBEC-signature mutagenesis. Clustering by mutation signature identified a high-mutation subset with 75% 5-year survival. mRNA expression clustering refined prior clustering analyses and identified a poor-survival "neuronal" subtype in which the majority of tumors lacked small cell or neuroendocrine histology. Clustering by mRNA, long non-coding RNA (lncRNA), and miRNA expression converged to identify subsets with differential epithelial-mesenchymal transition status, carcinoma in situ scores, histologic features, and survival. Our analyses identified 5 expression subtypes that may stratify response to different treatments.

Supplementary Methods from BRAFL597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors

Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Table S6 from Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations

Targeted, Massively Parallel Sequencing Identifies Novel Genetic Subsets Of Cutaneous Melanoma

Supplementary Table 14 from A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance

Data from <i>BRAF</i><sup>L597</sup> Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors

Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines.

Identifying Targets For Melanoma Therapy: Biological And Clinical Implications Of Braf L597 Mutants

Integration Of Melanoma Genotyping In Clinical Care.

Clonal architectures and driver mutations in metastatic melanomas

Supplementary Figure 2 from Large-scale Analysis of <i>pdgfra</i> Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib

High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens

Supplementary materials and methods from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma

Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations

Supplementary Figure 3 from Large-scale Analysis of <i>pdgfra</i> Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib

Weighted Correlation Network and Differential Expression Analyses Identify Candidate Genes Associated with BRAF Gene in Melanoma

Molecular Markers in Malignant Melanoma: Experience at an Nci-Designated Cancer Center

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Data from A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance